Central effects of tricyclic compounds on the endocrine system--an in vitro study

Prog Brain Res. 1992:91:89-92. doi: 10.1016/s0079-6123(08)62322-5.

Abstract

The present study involves the effects on corticotropin (ACTH) release of neuro- and thymoleptic tricyclic antidepressant compounds (TrcACs: chlorpromazine, promethazine, haloperidol, imipramine, amitriptyline) and their interactions with lysine-8-vasopressin (LVP) and corticosterone (B). As an in vitro model, 14-day monolayer pituitary cell cultures of Wistar rats were employed. The ACTH concentrations of the supernatant media were measured by radioimmunoassay. TrcACs augmented ACTH release; their combination with LVP, however, did not result in further stimulation; moreover, when combined with TrcACs + LVP, B did not inhibit, but rather paradoxically increased their ACTH-releasing action. As none of these phenomena were followed by relevant changes in intracellular cyclic adenosine monophosphate content, the mechanism of action may be proposed to involve a protein kinase C route.

MeSH terms

  • Adrenocorticotropic Hormone / metabolism*
  • Amitriptyline / pharmacology
  • Animals
  • Antidepressive Agents, Tricyclic / pharmacology*
  • Cells, Cultured
  • Chlorpromazine / pharmacology
  • Corticosterone / pharmacology
  • Cyclic AMP / metabolism*
  • Drug Interactions
  • Haloperidol / pharmacology
  • Imipramine / pharmacology
  • Lypressin / pharmacology
  • Pituitary Gland / drug effects
  • Pituitary Gland / metabolism
  • Pituitary Gland / physiology*
  • Promethazine / pharmacology
  • Rats
  • Rats, Wistar

Substances

  • Antidepressive Agents, Tricyclic
  • Amitriptyline
  • Lypressin
  • Adrenocorticotropic Hormone
  • Cyclic AMP
  • Promethazine
  • Haloperidol
  • Imipramine
  • Chlorpromazine
  • Corticosterone